Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.
Press releases published on March 31, 2025
Volt Lithium and Wellspring Hydro Enter Into Field Development Agreement Backed by Follow-On Grant from State of North Dakota
GlobeNewswire
·
March 31, 2025
Support from North Dakota Government: Additional funding of US$2,000,000 underscores continued support of Volt’s proprietary direct lithium extraction (“DLE”) technology. Accelerating Domestic Critical Minerals Production: Volt’s rapid timeline to …
Silynxcom Advances its Real-Time Vital Life Signs Monitoring Communication Solution for Combat
GlobeNewswire
·
March 31, 2025
New potentially life-saving solution aims to enhance combat communication and safety and will not require users to carry additional health monitoring equipment Netanya, Israel, March 31, 2025 (GLOBE NEWSWIRE) -- Silynxcom Ltd. (NYSE American: SYNX) (“ …
Robex Reports 2024 Financial Results
GlobeNewswire
·
March 31, 2025
QUEBEC CITY, March 31, 2025 (GLOBE NEWSWIRE) -- Robex Resources Inc. ("Robex" or the "Company") (TSXV: RBX) today reported its operational and financial results for 2024. Matthew Wilcox, Managing Director, commented: "2024 was a transformative year for …
Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression
GlobeNewswire
·
March 31, 2025
MALVERN, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they …
LIXTE Launches New Study to Determine if Certain Pre-Cancerous Cells Found in an Aging Population Can Be Eliminated by LB-100
GlobeNewswire
·
March 31, 2025
Pre-Clinical Study in Collaboration with Netherlands Cancer Institute is in addition to LIXTE’s Ongoing Clinical Trials for Ovarian and Colorectal Cancers PASADENA, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or …
Aprea Therapeutics Announces Dosing of Patient with HPV+ Head and Neck Squamous Cell Carcinoma (HNSCC) in Ongoing ACESOT-1051 Trial
GlobeNewswire
·
March 31, 2025
DOYLESTOWN, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments that exploit specific cancer cell vulnerabilities while …
Critical Metals Corp.’s Tanbreez Valued at $3 Billion With IRR of 180% and Significant Additional Upside Potential
GlobeNewswire
·
March 31, 2025
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp” or the “Company”), a leading mining development company, today announced that the Company has released an independent Preliminary Economic Assessment …
Veru to Participate in Fireside Chat at the Jones Healthcare and Technology Innovation Conference
GlobeNewswire
·
March 31, 2025
MIAMI, FL, March 31, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced that Mitchell …
Oncotelic Therapeutics Publishes New Research Demonstrating Positive Prognostic Impact of Methylated TGFB2 and MGMT in Adult Glioblastoma Patients, Introduces Interactive PDAOAI
GlobeNewswire
·
March 31, 2025
AGOURA HILLS, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB:OTLC) (“Oncotelic,” the “Company,” or “We”), a leader in RNA-based therapeutics, today announced the publication of its latest research paper, titled, “Positive …
Greenheart Gold Announces Trading on the OTCQB Venture Market in the United States
GlobeNewswire
·
March 31, 2025
LONGUEUIL, Quebec, March 31, 2025 (GLOBE NEWSWIRE) -- Greenheart Gold Inc. (TSXV: GHRT; OTCQB: GHRTF) (the “Company” or “Greenheart Gold”) is pleased to announce that its common shares commenced trading today on the OTCQB Venture Market (“OTCQB”) under the …
Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib
GlobeNewswire
·
March 31, 2025
LaunXP receives exclusive development and commercialization rights for vebreltinib in combination with an EGFR inhibitor in Asia (excluding mainland China, Hong Kong and Macau) for the treatment of non-small cell lung cancer (“NSCLC”) Apollomics to receive …
GRI Bio Bolsters Intellectual Property Portfolio with Granting of Two Global Patents for Europe and Japan
GlobeNewswire
·
March 31, 2025
Company committed to building a robust global patent estate across its innovative pipeline of NKT cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases LA JOLLA, CA, March 31, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: …
BetterLife Pharma Appoints New Director
GlobeNewswire
·
March 31, 2025
VANCOUVER, British Columbia, March 31, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company, is pleased to announce it has appointed Dr. Steven Sangha to its …
Cocrystal Pharma Reports 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
GlobeNewswire
·
March 31, 2025
BOTHELL, Wash., March 31, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the 12 months ended December 31, 2024, and provides updates on its antiviral product pipeline, upcoming …
Norden Crown Announces Name Change to Domestic Metals Corp.
GlobeNewswire
·
March 31, 2025
VANCOUVER, British Columbia, March 31, 2025 (GLOBE NEWSWIRE) -- Norden Crown Metals Corporation (“Norden Crown” or the “Company”) (TSXV:NOCR, OTC:NOCRF, Frankfurt:03E) announces it has changed its name to Domestic Metals Corp. (TSXV:DMCU) in accordance …
OKYO Pharma Announces Positive Data in Long-Term Stability of Urcosimod
GlobeNewswire
·
March 31, 2025
Urcosimod in Phase 2 clinical trial for Neuropathic Corneal Pain shown to have Long-Term Stability Urcosimod stable in single-use ampoules for more than 2½ years FDA requires drug to show long-term shelf stability for approval Daily administration to …
Nanox Announces Fourth Quarter of 2024 Financial Results and Provides Business Updates
GlobeNewswire
·
March 31, 2025
Recorded noted regulatory successes with FDA general use clearance and granting of CE Mark in the EU Advanced commercialization globally, signing new customer and channel partner agreements for Nanox.ARC and Nanox AI Management to host conference call and …
Steakholder Foods Reports 2024 Financial Results and Provides Business Update
GlobeNewswire
·
March 31, 2025
Rehovot, Israel, March 31, 2025 (GLOBE NEWSWIRE) -- Steakholder Foods Ltd. (Nasdaq: STKH), a leading innovator in 3D-printed meat and fish technology and cultivated cell innovation, is pleased to provide an annual business update for the year ended …
Revival Gold Delivers Compelling PEA Results and Attractive Potential Re-development Timeline for the Mercur Gold Project
GlobeNewswire
·
March 31, 2025
TORONTO, March 31, 2025 (GLOBE NEWSWIRE) -- Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival Gold” or the “Company”) is pleased to announce compelling results from a Preliminary Economic Assessment (“PEA”) on the Company’s Mercur Gold Project (“Mercur …
Maze Therapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Highlights
GlobeNewswire
·
March 31, 2025
MZE829 Phase 2 HORIZON Trial Enrolling Patients with APOL1 Kidney Disease (AKD); Initial Data Expected in Q1 2026 MZE782 Phase 1 Healthy Volunteer Trial Ongoing; Initial Data Expected in H2 2025 Raised $140 Million in Gross Proceeds in Upsized IPO in …